Literature DB >> 3605843

The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample.

B Rijcken, J P Schouten, S T Weiss, F E Speizer, R van der Lende.   

Abstract

The relationship of airway responsiveness to respiratory symptom prevalence has been studied in a cross-sectional analysis of a random subpopulation from a large-scale population study on chronic obstructive pulmonary disease (COPD) being conducted in the Netherlands. In 1,905 subjects with complete data on age, sex, area of residence, smoking habits, and respiratory symptom prevalence, airway responsiveness was assessed by a histamine challenge test. Subjects with a decrease in FEV1 of greater than or equal to 10% at a histamine concentration of less than or equal to 16 mg/ml were considered to be responders. Bronchial hyperresponsiveness appeared to be age dependent, with the proportion of responders increasing from 13% in those 14 to 24 yr of age to 40% in those 55 to 64 yr of age (p less than 0.001). Respiratory symptom outcomes included chronic cough, chronic phlegm, dyspnea, bronchitic episodes, persistent wheeze, and asthmatic attacks. Respiratory symptom prevalence rates were significantly higher in responders (p less than 0.001 for all symptoms). Cigarette smoking is known to be related to respiratory symptom prevalence and possibly to bronchial responsiveness. Because of these associations, we examined the relationship of bronchial responsiveness to respiratory symptoms within cigarette smoking categories. For all respiratory symptoms, it was found that, regardless of smoking category, responders were more likely to be symptomatic than were nonresponders. Odds ratios ranged from 1.7 for chronic cough to 4.4 for asthmatic attacks.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3605843     DOI: 10.1164/ajrccm/136.1.62

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  22 in total

Review 1.  Determinants and regulating processes in bronchial hyperreactivity.

Authors:  H J Neijens
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Epidemiology of bronchial hyperresponsiveness.

Authors:  A J Woolcock; J K Peat
Journal:  Clin Rev Allergy       Date:  1989

3.  Lung function and bronchial reactivity in farmers.

Authors:  M Iversen; R Dahl; E J Jensen; J Korsgaard; T Hallas
Journal:  Thorax       Date:  1989-08       Impact factor: 9.139

4.  Respiratory symptoms questionnaire for asthma epidemiology: validity and reproducibility.

Authors:  K M Venables; N Farrer; L Sharp; B J Graneek; A J Newman Taylor
Journal:  Thorax       Date:  1993-03       Impact factor: 9.139

5.  Relation between respiratory symptoms, pulmonary function and peak flow variability in adults.

Authors:  H M Boezen; J P Schouten; D S Postma; B Rijcken
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

6.  Respiratory symptoms and bronchial responsiveness in lifeguards exposed to nitrogen trichloride in indoor swimming pools.

Authors:  N Massin; A B Bohadana; P Wild; M Héry; J P Toamain; G Hubert
Journal:  Occup Environ Med       Date:  1998-04       Impact factor: 4.402

7.  Factors affecting peak expiratory flow variability and bronchial reactivity in a random population sample.

Authors:  B G Higgins; J R Britton; S Chinn; K K Lai; P G Burney; A E Tattersfield
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

8.  Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers.

Authors:  L Joos; T D Weir; J E Connett; N R Anthonisen; R Woods; P D Paré; A J Sandford
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

9.  Relation between respiratory symptoms, type of farming, and lung function disorders in farmers.

Authors:  M Iversen; B Pedersen
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

10.  Lung function 8-18 years after intermittent positive pressure ventilation for hyaline membrane disease.

Authors:  M J de Kleine; C M Roos; W J Voorn; H M Jansen; J G Koppe
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.